Bank of New York Mellon Corp
BankPosition in CTKB — Cytek Biosciences, Inc.
CIK 1390777
NEW YORK, NY
Position in CTKB
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,645,419
-$1,014,365 QoQ
Shares Held
371,427
-39.0% QoQ
Ownership
0.286%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 154 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 81%
Shared 0%
None 19%
Common Shares in CTKB Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $5,923,174,094 across 79 Medical Devices names. CTKB ranks #47 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EW |
Edwards Lifesciences Corp
|
14,084,483 | $1,274,082,319 | |
| 2 | MDT |
Medtronic plc
|
14,694,253 | $1,149,531,398 | |
| 3 | SYK |
Stryker Corp
|
3,548,516 | $1,117,214,769 | |
| 4 | ABT |
Abbott Laboratories
|
9,991,899 | $906,664,905 | |
| 5 | BSX |
Boston Scientific Corp
|
7,943,553 | $339,030,832 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
2,639,900 | $168,979,991 | |
| 7 | DXCM |
Dexcom Inc
|
2,309,648 | $155,554,782 | |
| 8 | STE |
STERIS plc
|
503,402 | $106,001,351 |
All Filings in CTKB
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,645,419 | 371,427 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $2,659,784 | 608,647 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $3,221,539 | 637,929 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $2,337,281 | 673,569 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $2,379,702 | 699,913 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $2,776,530 | 692,402 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $4,742,299 | 730,709 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $3,983,501 | 719,044 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $4,487,774 | 804,261 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $5,198,115 | 774,682 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $7,462,620 | 818,270 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $4,557,200 | 825,580 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $6,490,646 | 760,029 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $3,589,071 | 390,541 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $4,053,736 | 397,036 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,800,179 | 394,034 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,519,321 | 327,989 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,871,090 | 266,335 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $862,658 | 52,859 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $825,762 | 38,569 | Shares | Defined | 2021-11-18 | |
| No filing history on record for this holder in this stock. | ||||||